Shareholders are usually looking at the stocks that not only promise a consistent increase but also have their dynamics with the amount of movement in fundamentals. QuantumScape, Civeo and Agenus are bright this week since all three are experiencing promising earnings growth accelerations. The use of earnings acceleration sessions shifts the focus to firms in which growth is accelerating. They are the stocks that the crowd does not pay much attention to, but when the development of earnings accelerates, investors do wake up, and price momentum can rapidly occur.
One such stock in focus is Civeo, which provides lodgings and logistic services to the worldwide natural and resource sector. Civeo is not just recovering, but gaining momentum on old predicaments, with the projected growth in earnings at almost 70% this year.
It is a stunning rebound and particularly following a tricky bit when net income went negative, depicting the capacity of the management to change and seize new opportunities in the industry. Another company that is worth a mention is Agenus. Being a clinical-stage biotech company, Agenus is devoted to transforming the landscape of cancer treatment by using immune approaches. The prediction of the earnings growth rate of its company is greater than 100% of the coming year, which is outstanding regarding its sector.
Such fast-tracking is an indication of future breakthroughs or commercialization success potential within its pipeline. It is thus a strong, high-risk, high-reward opportunity to make it of great interest to forward-thinking investors. QuantumScape has one of the brightest records in solid-state battery development, which is expected to have an increase in its earnings by a factor of more than ten this year. All three stocks have a Zacks 2 (Buy) rank, which is a clear indication of analyst support.
These trends in acceleration of patterns have a tendency to indicate larger-scale changes when they emerge at an industry level or even the firm level. Altogether, earnings acceleration is one of the time-tested methods of beating the market. Civeo and Agenus are both demonstrating a rare convergence of turnaround momentum and high expectations, and thus are businesses that cannot be overlooked by thinking investors.
